here it is topper, ??? no need for bta thread , page-3

sirtex conferences with big pharma including Genenetech, Pfizer, and Aventis advising of positive results with Sir Spheres and all of these newer 100 billion market cap companies chemotherapy drugs in liver cancer and metastatic disease and expanding indications for Sir Spheres will send share of sirtex = SRX over $3 and then $4 short term. This is not appreciated YET by the investing public. The Sir Spheres are now in over 130 centers worldwide and expanding everyday. Tratment is $ 14,000 per patient with average of 2 tx per patient for very significant improvement. The worldwide incidence of this metastatic disease is in the millions of people and the market potential for combination therapy using Sir Spheres is in the billions. Float is small so I have been using limit orders. Link is
http:///www.cancerconferences.com/
Under the 4th International Congress